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LETTERS TO THE EDITOR
Viability of the Health Protection Account in Hong Kong
To the Editor—Law and Yip’s1 attempt to model the
sustainability of the proposed Health Protection Account
(HPA) is a useful first step in debating Hong Kong’s health
financing options, given the relatively muted evidence-based
discussion of the topic thus far. However, we have found
several methodological inconsistencies and queries that
should be further addressed.
First, there appears to be some confusion over the
economic concepts of quantity and price in Table 1. The
growth projection of the notional unit costs of hospitalisa-
tion (HK$3622) and specialist consultation (HK$549)
should not be based on the aggregate, unadjusted medical
expenditure annual growth rate. More importantly, the 5%
annual expenditure growth rate was derived from the
period 1993 to 2000, during which the Hospital Authority
underwent accelerated structural expansion in its first
decade of operation. Many of these costs were non-
recurrent and should not have been included in the growth
projection exercise. In addition, the nominal medical
expenditure reported in Table 1 had not been adjusted for
population changes and utilisation patterns. For instance,
the shifting market share from private to public facilities
during that period would have artificially accentuated the
apparent growth in overall health services utilisation for the
population.
Second, wage growth for an individual aged 40 to
64 years should be distinguished from real growth in
national income. Therefore, adopting 3% as the real gross
domestic product growth rate to project salary growth may
be problematic.
Third, the management of HPA funds will likely follow
the practice adopted by the Mandatory Provident Fund that
is invested in managed portfolios. The long-term investment
rate of return will likely be more generous than that derived
from the average inflation-adjusted bank savings rate
of 2.5%.
Fourth, the discussion section seems to have missed the
critical point that the potential benefits of changing the means
of financing health care are not limited to increasing the
funding sources, but also changing behaviour. It is naive to
see this scheme as an alternative to raising fees, but instead,
it can be viewed as a complementary system that may also
help to develop more appropriate care-seeking behaviour.
Lastly, analysing average health care costs is mislead-
ing and does not allow for a key question to be asked, namely,
instead of asking what percentage of the total health bill is
covered, a more relevant question would be whether it can
cover a significant percentage of the individual bills for a
significant number of people. This is essential, given that
this scheme is person-based, not social insurance–based. For
example, if expenses follow the 90/10 rule (10% of the popu-
lation incurring 90% of the expenses, which is possible),
the scheme might achieve 30% coverage for many people.
A more sophisticated analysis, using longitudinal data, is
therefore needed before concluding that the scheme will not
work.
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To the Editor—We would like to respond to the comments
by Bacon-Shone et al on our paper entitled ‘Viability of the
Health Protection Account in Hong Kong’.1 We welcome
any suggestions and criticisms that can help progress the
debate and discussions on this topic. Our corresponding
replies to the queries raised are noted below.
First, the alleged confusion over the economic concepts
of quantity and price in Table 1—a 5% average growth rate
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is estimated based on past data after adjusting for inflation.
A smaller or larger value is still very much an unknown.
The increase in medical treatment, medicine, cost of
acquiring the latest medical equipment, and the increase in
hospital patient days would possibly offset any reduction in
the non-recurrent expenses.
Second, alleged problems with the adopted growth
rate—we adopted the assumption of 3% of gross domestic
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product (GDP) growth from the Harvard report.2 In
2001, salary growth was less than the GDP growth, and the
financial status of the Health Protection Account (HPA)
would be worse if the 2001 situation prevailed.
Third, suggestion that the rate of return “will likely” be
more generous—unfortunately, the Mandatory Provident
Fund is invested in a number of managed portfolios that
have reported negative returns since its inception. We
cannot be too optimistic with a poor economy and high un-
employment rate. Furthermore, Fig 1 provides a whole range
of return rates for the readers’ consideration.1 The savings
rate of 2.5% is just one of the many possible scenarios.
Fourth, alleged potential benefit of the HPA—whether
the introduction of the HPA can change patients’ care-
seeking behaviour is speculative. We would expect the
behaviour of patients to depend on their health status and
not the availability of the HPA. However, it may well be a
complementary system that may encourage or help to de-
velop more appropriate care-seeking behaviour in Hong
Kong.
Fifth, alleged misleading analyses—the HPA is not a
social insurance; it is a personal savings plan to cover med-
ical expenditure after the age of 65 years. As a consequence,
the cost of providing medical treatment to this needy
age-group cannot be shared with the other accounts. The
financial and instrumental burden upon the government to
provide medical treatment and services will not subsequently
be reduced. Ten percent of the population will still have to
rely on the government, but the HPA of the remaining 90%
cannot be used to alleviate the government burden.
Certainly, we agree that longitudinal data can provide
further information. To the best of our knowledge, we are
not aware of the existence of such data or, if they do exist,
the relevant authority has not made them available. If such
data do not exist, it may be time to conduct a large-scale
longitudinal study to advance the medical and public health
research development in Hong Kong. The standard of
medical and health services in Hong Kong is excellent. The
Government and the Hospital Authority should be proud of
what they have already achieved. They have enhanced
productivity and are now to consider revamping the fees
and charges, which, in turn, would reduce the deficit. If
the money from any mandatory medical savings scheme can
be used to purchase services from private health insurance,
it might affect the medical seeking behaviour of the
community. Subsequently, the private sector would play a
more significant role in health care delivery. For the time
being, the choice to the government to reduce its health
care deficit is limited, apart from the gradual increase of
fees and charges. It is encouraging to note that the govern-
ment is to investigate the issue further. Let us emphasise
that any form of mandatory medical savings scheme should
be able to demonstrate its usefulness, relevance, and
viability.
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To the Editor—I read with interest the Editorial “Liver
transplantation in Hong Kong” written by Chui.1
The information about liver transplantation mentioned
in the article is valid except for the part of adult-to-adult
right-lobe live donor liver transplantation. To place the his-
torical aspect into the correct perspective, I wish to point
out that the adult-to-adult right-lobe live donor liver trans-
plantation was actually initiated by us at the University
of Hong Kong Medical Centre, Queen Mary Hospital, in
1996.2 The operation was subsequently adopted by numer-
ous liver transplant centres throughout the world. Our pub-
lication of the first seven cases2 has been cited 105 times in
literature on right-lobe live donor liver transplantation. The
innovation of right-lobe live donor liver transplantation is a
Liver transplantation in Hong Kong
major contribution to the recent development of liver trans-
plantation from Hong Kong.
ST Fan, MD, FHKAM (Surgery)
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Hong Kong
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